Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0120/2022
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0120/2022
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0120/2022
